Liquid Profiling for lung cancer patients -- MEDICA - World Forum for Medicine

25.07.2019

ViennaLab Diagnostics GmbH

Liquid Profiling for lung cancer patients

ViennaLab Diagnostics has released their first real-time PCR assay for monitoring lung cancer patients eligible for the alternative treatment with osimertinib (Tagrisso) due to acquired resistance to EGFR-tyrosine kinase inhibitor (TKI) therapy:
EGFR T790M RealFast Assay.
For proper sample preparation, ViennaLab is offering a column-based Plasma cfDNA Extraction Kit allowing isolation of high-purity circulating cell-free DNA from fresh or frozen human plasma.

Exhibitor Data Sheet